ScholarIQanswers from OpenAlex & ORCID
Nils Erik Gilhus
ResearcherPublications, citations & collaboration network
Nils Erik Gilhus is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Nils Erik Gilhus have?
ScholarIQindexed works
Nils Erik Gilhus has 421 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nils Erik Gilhus have?
ScholarIQcitation count
Nils Erik Gilhus has 18,634 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Nils Erik Gilhus?
ScholarIQh-index
Nils Erik Gilhus has an h-index of 67 in OpenAlex.
What is the i10-index of Nils Erik Gilhus?
ScholarIQi10-index
Nils Erik Gilhus has an i10-index of 232 in OpenAlex.
What is the ORCID of Nils Erik Gilhus?
ScholarIQorcid
The ORCID for Nils Erik Gilhus is on the source record.
What is the OpenAlex record for Nils Erik Gilhus?
ScholarIQopenalex
The OpenAlex for Nils Erik Gilhus is on the source record.
What are the most-cited papers on Nils Erik Gilhus?
ScholarIQmost cited works
International consensus guidance for management of myasthenia gravis
Donald B. Sanders, Gil I. Wolfe, Michael Benatar, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L. Kuntz, Janice M. Massey, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David P. Richman, Jan J.G.M. Verschuuren, Pushpa Narayanaswami
International Consensus Guidance for Management of Myasthenia Gravis
Pushpa Narayanaswami, Donald B. Sanders, Gil I. Wolfe, Michael Benatar, Gabriel Cea, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L. Kuntz, Janice M. Massey, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David P. Richman, Jan J.G.M. Verschuuren
Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force
Florian Deisenhammer, Aleš Bartoš, R. Egg, Nils Erik Gilhus, Gavin Giovannoni, Sebastian Rauer, Finn Sellebjerg
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F. Howard, Saskia Bresch, Angela Genge, Channa Hewamadduma, John L. Hinton, Yessar Hussain, Raúl Juntas‐Morales, Henry J. Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D. Weiss, Małgorzata Zajda, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W. Duda, Romana Lowcock, Mark Vanderkelen, Maria Isabel Leite, Dylan Sembinelli, Jeanne Teitelbaum, Michael Nicolle, E Bernard, Juliette Svahn, Marco Spinazzi, Tanya Stojkovic, Sophie Demeret, Nicolas Weiss, Loïc Le Guennec, Sihame Messai, Christine Tranchant, Aleksandra Nadaj‐Pakleza, Jean‐Baptiste Chanson, Muhtadi Suliman, Leila Zaidi, Céline Tard, Peggy Lecointe, Jana Zschüntzsch, Jens Schmidt, Stefanie Glaubitz, Rachel Zeng, Matthias Scholl, Markus C. Kowarik, Ulf Ziemann, Markus Krumbholz, Pascal Martin, Christoph Ruschil, Jutta Dünschede, Roswitha Kemmner, Natalie Rumpel, Benjamin Berger, Andreas Totzeck, Tim Hagenacker, Benjamin Stolte, Raffaele Iorio, Amelia Evoli, Silvia Falso, Carlo Antozzi, Rita Frangiamore, Fiammetta Vanoli, Elena Rinaldi, Kazushi Deguchi, Naoya Minami, Yuriko Nagane, Yasushi Suzuki, Sayaka Ishida, Shigeaki Suzuki, Jin Nakahara, Astushi Nagaoka, Shunsuke Yoshimura, Shingo Konno, Youko Tsuya, Akiyuki Uzawa, Tomoya Kubota, Masanori Takahashi, Tatsusada Okuno, Hiroyuki Murai, Nils Erik Gilhus, Marion Boldingh, Tone Hakvåg Rønning, Urszula Chyrchel-Paszkiewicz, Klaudiusz Kumor, Tomasz Zieliński, Krzysztof Banaszkiewicz, Michał Błaż, Agata Kłósek, Mariola Matysiak, Andrzej Szczudlik, Aneta Paśko, L Szczechowski, Marta Banach, Jan Ilkowski, S. Kapetanovic García, Patricia Ortiz Bagan, Ana Belén Cánovas Segura